296 related articles for article (PubMed ID: 14551180)
1. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers.
Teichert J; Hermann R; Ruus P; Preiss R
J Clin Pharmacol; 2003 Nov; 43(11):1257-67. PubMed ID: 14551180
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease.
Teichert J; Tuemmers T; Achenbach H; Preiss C; Hermann R; Ruus P; Preiss R
J Clin Pharmacol; 2005 Mar; 45(3):313-28. PubMed ID: 15703366
[TBL] [Abstract][Full Text] [Related]
3. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers.
Teichert J; Kern J; Tritschler HJ; Ulrich H; Preiss R
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):625-8. PubMed ID: 9876998
[TBL] [Abstract][Full Text] [Related]
4. Single dose bioavailability and pharmacokinetic study of a innovative formulation of α-lipoic acid (ALA600) in healthy volunteers.
Mignini F; Capacchietti M; Napolioni V; Reggiardo G; Fasani R; Ferrari P
Minerva Med; 2011 Dec; 102(6):475-82. PubMed ID: 22193379
[TBL] [Abstract][Full Text] [Related]
5. New metabolic pathways of alpha-lipoic acid.
Schupke H; Hempel R; Peter G; Hermann R; Wessel K; Engel J; Kronbach T
Drug Metab Dispos; 2001 Jun; 29(6):855-62. PubMed ID: 11353754
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
7. Plasma protein oxidation in aging rats after alpha-lipoic acid administration.
Cakatay U; Kayali R
Biogerontology; 2005; 6(2):87-93. PubMed ID: 16034676
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetic of celecoxib in healthy Thai volunteers.
Itthipanichpong C; Chompootaweep S; Wittayalertpanya S; Kemsri W; Thaworn N; Lilitkarntrakul P; Parikamsil S
J Med Assoc Thai; 2005 May; 88(5):632-8. PubMed ID: 16149679
[TBL] [Abstract][Full Text] [Related]
11. The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects.
Carlson DA; Smith AR; Fischer SJ; Young KL; Packer L
Altern Med Rev; 2007 Dec; 12(4):343-51. PubMed ID: 18069903
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic assay for alpha-lipoic acid and five of its metabolites in human plasma and urine.
Teichert J; Preiss R
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Apr; 769(2):269-81. PubMed ID: 11996493
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of different formulations of tioctic (alpha-lipoic) acid in healthy volunteers.
Amenta F; Traini E; Tomassoni D; Mignini F
Clin Exp Hypertens; 2008 Nov; 30(8):767-75. PubMed ID: 19021026
[TBL] [Abstract][Full Text] [Related]
14. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic study of ketoprofen (19.583 R.P.) in man using the tritiated compound.
Delbarre F; Roucayrol JC; Amor B; Ingrand J; Bourat G; Fournel J; Courjaret J
Scand J Rheumatol Suppl; 1976; 1976(0):45-52. PubMed ID: 1068515
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers.
Stoltz R; Parisi S; Shah A; Macciocchi A
Biopharm Drug Dispos; 2004 Nov; 25(8):329-37. PubMed ID: 15378559
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
18. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humans.
Dalvie D; Chen W; Zhang C; Vaz AD; Smolarek TA; Cox LM; Lin J; Obach RS
Drug Metab Dispos; 2008 Nov; 36(11):2185-98. PubMed ID: 18694908
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and metabolism of oral diosmin in healthy volunteers.
Cova D; De Angelis L; Giavarini F; Palladini G; Perego R
Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):29-33. PubMed ID: 1551741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
